Healthcare provider profile · identity verified

Michael Albert Morale, NP-C

Nurse Practitioner · UNION, NJ · NPI 1053846782

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	266	40
Atorvastatin Calcium	Atorvastatin Calcium	250	43
Furosemide	Furosemide	202	46
Prednisone	Prednisone	188	86
Gabapentin	Gabapentin	177	23
Pantoprazole Sodium	Pantoprazole Sodium	152	28
Escitalopram Oxalate	Escitalopram Oxalate	151	21
Nystatin	Nystatin	136	43
Levothyroxine Sodium	Levothyroxine Sodium	131	25
Potassium Chloride	Potassium Chloride	131	24
Eliquis	Apixaban	125	21
Trazodone Hcl	Trazodone Hcl	112	23
Donepezil Hcl	Donepezil Hcl	111	19
Sertraline Hcl	Sertraline Hcl	111	18
Metoprolol Succinate	Metoprolol Succinate	109	20
Lisinopril	Lisinopril	106	15
Divalproex Sodium	Divalproex Sodium	88	15
Mirtazapine	Mirtazapine	87	16
Quetiapine Fumarate	Quetiapine Fumarate	84	14
Alprazolam	Alprazolam	83	32
Omeprazole	Omeprazole	83	11
Losartan Potassium	Losartan Potassium	82	17
Metformin Hcl	Metformin Hcl	67	11
Tamsulosin Hcl	Tamsulosin Hcl	66	11
Naproxen	Naproxen	65	25
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	63	suppressed
Clopidogrel	Clopidogrel Bisulfate	62	12
Diclofenac Sodium	Diclofenac Sodium	61	18
Memantine Hcl	Memantine Hcl	61	11
Tramadol Hcl	Tramadol Hcl	61	18
Doxycycline Hyclate	Doxycycline Hyclate	60	43
Levetiracetam	Levetiracetam	59	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	55	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	55	45
Duloxetine Hcl	Duloxetine Hcl	55	suppressed
Famotidine	Famotidine	54	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	54	suppressed
Latanoprost	Latanoprost	52	suppressed
Lactulose	Lactulose	49	20
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	49	35
Carvedilol	Carvedilol	46	suppressed
Torsemide	Torsemide	46	suppressed
Mupirocin	Mupirocin	44	35
Hydrochlorothiazide	Hydrochlorothiazide	42	suppressed
Myrbetriq	Mirabegron	42	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	42	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	42	suppressed
Fluticasone Propionate	Fluticasone Propionate	41	11
Atenolol	Atenolol	40	suppressed
Metolazone	Metolazone	40	suppressed
Simvastatin	Simvastatin	34	suppressed
Lorazepam	Lorazepam	33	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	32	17
Ozempic	Semaglutide	32	suppressed
Cephalexin	Cephalexin	31	28
Ondansetron Hcl	Ondansetron Hcl	31	20
Lithium Carbonate	Lithium Carbonate	30	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	30	suppressed
Pravastatin Sodium	Pravastatin Sodium	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Midodrine Hcl	Midodrine Hcl	29	suppressed
Azithromycin	Azithromycin	27	19
Risperidone	Risperidone	27	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	26	suppressed
Pregabalin	Pregabalin	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Hydrocortisone	Hydrocortisone	24	19
Loperamide	Loperamide Hcl	24	14
Spironolactone	Spironolactone	24	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Amiodarone Hcl	Amiodarone Hcl	22	suppressed
Amoxicillin	Amoxicillin	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Ketoconazole	Ketoconazole	21	suppressed
Baclofen	Baclofen	20	suppressed
Timolol Maleate	Timolol Maleate	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	19	suppressed
Folic Acid	Folic Acid	19	suppressed
Humalog Kwikpen U-100	Insulin Lispro	19	suppressed
Ssd	Silver Sulfadiazine	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	suppressed
Ammonium Lactate	Ammonium Lactate	17	12
Combigan	Brimonidine Tartrate/Timolol	17	suppressed
Ramipril	Ramipril	17	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Celecoxib	Celecoxib	14	suppressed
Glipizide	Glipizide	14	suppressed
Klor-Con 10	Potassium Chloride	14	suppressed
Travoprost	Travoprost	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Lumigan	Bimatoprost	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Alendronate Sodium	Alendronate Sodium	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Belsomra	Suvorexant	12	suppressed
Bromfenac Sodium	Bromfenac Sodium	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Digoxin	Digoxin	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	12	suppressed
Finasteride	Finasteride	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Clindamycin Hcl	Clindamycin Hcl	11	suppressed
Insulin Aspart Flexpen	Insulin Aspart	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	11	suppressed
Nateglinide	Nateglinide	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed
Zonisamide	Zonisamide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error